Associated Papers
Mechanisms of action and resistance in histone methylation-targeted therapy.
Yamagishi M et al.
Nature, 2024
38383791 (PubMed )
Supplement: 41586_2024_7103_MOESM3_ESM.xlsx › Sup_Table_4
CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
Sakamoto Y et al.
Hematological Oncology, 2022
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Sakamoto Y et al.
British Journal of Haematology, 2021
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Sakihama S et al.
Cancer Science, 2021
33426772 (PubMed )
Supplement: CAS-112-1300-s002.xlsx › Table_S4
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma.
Fujii K et al.
The Journal of Pathology. Clinical Research, 2021
cDNA-Based Mutation Screening Using a Combination of High-Resolution Melting Curve and Fragment Analysis Facilitates Efficient CCR4 Mutation Analysis in Adult T-Cell Leukemia/Lymphoma.
Mizuta S et al.
American Journal of Clinical Pathology, 2020
Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
Manso R et al.
Oncotarget, 2018
29662631 (PubMed )
Supplement: oncotarget-09-16124-s002.xls › Supplementary_Table_3
CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N et al.
The Journal of Pathology, 2016
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.
Wang L et al.
Nature Genetics, 2015
Integrated molecular analysis of adult T cell leukemia/lymphoma.
Kataoka K et al.
Nature Genetics, 2015
Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.
Nakagawa M et al.
The Journal of Experimental Medicine, 2014
Select a paper to view details